Hyperphosphorylated tau protein is a major component of neurofibrillary tangles, a prominent intracellular hallmark of Alzheimer's disease. Both hyperphosphorylated tau and neurofibrillary tangles have been shown to correlate with dementia in Alzheimer's disease, but the relationship between hyperphosphorylation and tangle formation is not clear. Using a cell-free in vitro model system, in which tau polymerization is induced by arachidonic acid, we show that GSK-3β phosphorylation of pre-assembled tau filaments makes those filaments prone to coalesce into large neurofibrillary tangle-like structures. Five phosphorylation sites, S199, T205, T231, S396 and S404, were identified in the phosphorylated filaments; many of the five are within epitopes recognized by Alzheimer's disease-associated antibodies. These tangle-like structures are optically visible and are similar to those formed by polymerization of GSK-3β phosphorylated tau monomer and to those isolated from Alzheimer's disease tissue. We conclude that the phosphorylation of tau by GSK-3β either prior to or following polymerization promotes polymer/polymer interactions that result in stable clusters of tau filaments.
Introduction
Neurofibrillary tangles (NFT), a prominent intracellular hallmark of Alzheimer's disease (AD), are composed primarily of hyperphosphorylated tau protein that has polymerized into straight and paired-helical filaments (reviewed in Buee et al., 2000; Lee et al., 2001; Stoothoff and Johnson, 2005) . Tau protein is normally very soluble and functions to regulate neuronal microtubule dynamics. Although tau's function is normally modulated via controlled phosphorylation and de-phosphorylation, the pathological deregulation of tau phosphorylation correlates with dementia in AD (Holzer et al., 1994) and appears to precede polymerization and NFT formation (Bancher et al., 1989; Vincent et al., 1998) . The kinase(s) responsible for the hyperphosphorylation of tau in AD has not been identified, although tau is readily phosphorylated by numerous kinases (reviewed in Buee et al., 2000; Lee et al., 2001; Stoothoff and Johnson, 2005) . One leading candidate for this role in AD is glycogen synthase kinase-3β (GSK-3β).
GSK-3β is an attractive candidate for modulating tau phosphorylation levels in AD since GSK-3β is expressed in neurons, GSK-3β activity levels are increased in AD brain (Leroy et al., 2007) , and GSK-3β phosphorylates many of the same sites on tau that are phosphorylated in AD (Balaraman et al., 2006; Illenberger et al., 1998; Ishiguro et al., 1993; Song and Yang, 1995) . Additionally, many of the sites phosphorylated by GSK-3β are proline directed sites which were demonstrated to be critical for tau neurotoxicity in a transgenic Drosophila model (Steinhilb et al., 2007) . Lastly, GSK-3β greatly increased the severity of disease in transgenic animal models of AD when expressed in conjunction with tau (Engel et al., 2006; Jackson et al., 2002) .
Pathological tau polymerization can be modeled in vitro using a well established cell-free system to induce the formation of tau filaments (Abraha et al., 2000; Barghorn and Mandelkow, 2002; Carlson et al., 2007; Chirita et al., 2003; DeTure et al., 2006; King et al., 1999; King et al., 2000; Rankin et al., 2007) . We have previously employed this system to investigate the effects of GSK-3β phosphorylation on the polymerization of tau (Rankin et al., 2007) . We found that phosphorylation of monomeric tau by GSK-3β resulted in arachidonic acid-induced filaments clustering into tangle-like structures similar to those isolated from AD brain (Rankin et al., 2007) . In the current study, we are testing the hypothesis that the polymerization of tau can precede phosphorylation by GSK-3β and the subsequent clustering of tau filaments into NFT-like structures. We have found that GSK-3β phosphorylates pre-assembled tau filaments at a minimum of five sites causing the filaments to coalesce into optically visible tangle-like structures similar to those formed by prephosphorylated tau and those isolated from AD brain. These results suggest that tau phosphorylation, regardless of whether it precedes or follows polymerization, causes the formation of neurofibrillary tangle-like structures and that the formation of these structures could be responsible for the appearance of optically visible tau pathology in AD brain. Neurobiology of Disease 31 (2008) 368-377 
